Novartis India Limited Sustainability Profile
Novartis India Limited, a subsidiary of the global healthcare leader Novartis AG, is headquartered in Mumbai, India. Established in 1947, the company has made significant strides in the pharmaceutical industry, focusing on innovative medicines, generics, and biosimilars. With a strong presence across major operational regions in India, Novartis India is dedicated to addressing unmet medical needs through its diverse portfolio. The company’s core products include patented pharmaceuticals in areas such as oncology, cardiology, and ophthalmology, distinguished by their cutting-edge research and development. Novartis India has consistently maintained a strong market position, recognised for its commitment to quality and patient-centric solutions. Notable achievements include numerous awards for innovation and excellence in healthcare, solidifying its reputation as a trusted name in the Indian pharmaceutical landscape.
DitchCarbon Score
How does Novartis India Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Novartis India Limited's score of 100 is higher than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Novartis India Limited currently does not have specific carbon emissions data available for the most recent year, as indicated by the absence of emissions figures. However, the company is part of a broader corporate family under Novartis AG, which influences its climate commitments and initiatives. As a current subsidiary of Novartis AG, Novartis India Limited inherits its climate targets and commitments. Novartis AG has established various initiatives aimed at reducing carbon emissions, including targets set through the Science Based Targets initiative (SBTi), the Carbon Disclosure Project (CDP), and the RE100 initiative, all of which are cascaded to Novartis India Limited. These initiatives reflect a commitment to sustainability and reducing the overall carbon footprint across its operations. While specific reduction targets for Novartis India Limited are not detailed, the overarching goals from Novartis AG suggest a strong commitment to addressing climate change and reducing emissions in line with global standards. The company is actively engaged in efforts to enhance its environmental performance, although specific metrics and achievements at the subsidiary level remain unspecified.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 583,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 922,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 | - | 0,000,000,000 | 0,000,000,000 | 000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
How Carbon Intensive is Novartis India Limited's Industry?
How Carbon Intensive is Novartis India Limited's Location?
Novartis India Limited's Scope 3 Categories Breakdown
Novartis India Limited's Scope 3 emissions, which decreased by 5% last year and increased significantly since 2013, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 78% of Scope 3 emissions.
Top Scope 3 Categories
Novartis India Limited's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Novartis India Limited has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
